Today, the Governments of Canada and Nunavut signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $7.3 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.